+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical and functional characterization of a patient carrying a compound heterozygous pericentrin mutation and a heterozygous IGF1 receptor mutation



Clinical and functional characterization of a patient carrying a compound heterozygous pericentrin mutation and a heterozygous IGF1 receptor mutation



Plos One 7(5): E38220



Intrauterine and postnatal longitudinal growth is controlled by a strong genetic component that regulates a complex network of endocrine factors integrating them with cellular proliferation, differentiation and apoptotic processes in target tissues, particularly the growth centers of the long bones. Here we report on a patient born small for gestational age (SGA) with severe, proportionate postnatal growth retardation, discreet signs of skeletal dysplasia, microcephaly and moyamoya disease. Initial genetic evaluation revealed a novel heterozygous IGF1R p.Leu1361Arg mutation affecting a highly conserved residue with the insulin-like growth factor type 1 receptor suggestive for a disturbance within the somatotropic axis. However, because the mutation did not co-segregate with the phenotype and functional characterization did not reveal an obvious impairment of the ligand depending major IGF1R signaling capabilities a second-site mutation was assumed. Mutational screening of components of the somatotropic axis, constituents of the IGF signaling system and factors involved in cellular proliferation, which are described or suggested to provoke syndromic dwarfism phenotypes, was performed. Two compound heterozygous PCNT mutations (p.[Arg585X];[Glu1774X]) were identified leading to the specification of the diagnosis to MOPD II. These investigations underline the need for careful assessment of all available information to derive a firm diagnosis from a sequence aberration.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052105969

Download citation: RISBibTeXText

PMID: 22693602

DOI: 10.1371/journal.pone.0038220


Related references

Novel compound heterozygous ASXL3 mutation causing Bainbridge-ropers like syndrome and primary IGF1 deficiency. International Journal of Pediatric Endocrinology 2017: 8, 2017

Bleeding tendency and impaired platelet function in a patient carrying a heterozygous mutation in the thromboxane A2 receptor. Journal of Thrombosis and Haemostasis 9(5): 1040-1048, 2011

Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene. Stem Cell Research 27: 90-94, 2018

Molecular characterization of the first missense mutation in the fibrinogen Aalpha-chain gene identified in a compound heterozygous afibrinogenemic patient. Biochimica et Biophysica Acta 1772(7): 781-787, 2007

Thirteen cystic fibrosis patients, 12 compound heterozygous and one homozygous for the missense mutation G85E: a pancreatic sufficiency/insufficiency mutation with variable clinical presentation. Journal of Medical Genetics 33(10): 820-822, 1996

Pregnancy-associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone. British Journal of Haematology 123(2): 327-334, 2003

Penetrance of eye defects in mice heterozygous for mutation of Gli3 is enhanced by heterozygous mutation of Pax6. Bmc Developmental Biology 6: 46, 2006

Renal transplantation experience in a patient with factor V Leiden homozygous, MTHFR C677T heterozygous, and PAI heterozygous mutation. Pediatric Transplantation 19(5): E126-E129, 2016

Classical phenotype of Laron syndrome in a girl with a heterozygous mutation and heterozygous polymorphism of the growth hormone receptor gene. Journal of Pediatric Endocrinology & Metabolism 17(3): 371-374, 2004

A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. Journal of Thrombosis and Haemostasis 7(8): 1356-1363, 2009

Identification of a compound heterozygous mutation of ABCC2 in a patient with hyperbilirubinemia. Molecular Medicine Reports 16(3): 2830-2834, 2017

Severe clinical course in a patient with homozygous mtDNA polymerase gamma mutation (A467T) and heterozygous thymidine phosphorylase mutation (A465T). A possible digenic effect?. 2007

Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene. Clinical Endocrinology 67(3): 385-392, 2007

Novel compound heterozygous mutation of MLYCD in a Chinese patient with malonic aciduria. Molecular Genetics and Metabolism 105(1): 79-83, 2012

Analysis on the novel compound heterozygous mutation FⅪ of a patient with hereditary factor Ⅺ deficiency. Zhonghua Yi Xue Za Zhi 97(48): 3774-3778, 2018